Methodological considerations on real-world evidence studies of monoclonal antibodies against the CGRP-pathway for migraine: a systematic review

被引：0
作者：
Nicolas Vandenbussche
Karolina Pisarek
Koen Paemeleire
机构：
[1] Ghent University Hospital,Department of Neurology
[2] Ghent University,Faculty of Medicine and Health Sciences
来源：
The Journal of Headache and Pain | / 24卷
关键词：
Methodology; Migraine; CGRP; Real-world evidence; Clinical trials;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study
    Grazzi, Licia
    Giossi, Riccardo
    Montisano, Danilo Antonio
    Canella, Mattia
    Marcosano, Marilena
    Altamura, Claudia
    Vernieri, Fabrizio
    JOURNAL OF HEADACHE AND PAIN, 2024, 25 (01)
  • [22] Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study
    Licia Grazzi
    Riccardo Giossi
    Danilo Antonio Montisano
    Mattia Canella
    Marilena Marcosano
    Claudia Altamura
    Fabrizio Vernieri
    The Journal of Headache and Pain, 25
  • [23] Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis
    Drellia, Konstantina
    Kokoti, Lili
    Deligianni, Christina, I
    Papadopoulos, Dimitrios
    Mitsikostas, Dimos D.
    CEPHALALGIA, 2021, 41 (07) : 851 - 864
  • [24] Monoclonal Antibodies Targeting CGRP to Treat Vestibular Migraine: A Rapid Systematic Review and Meta-Analysis
    Frosolini, Andrea
    Lovato, Andrea
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2024, 76 (04) : 3737 - 3744
  • [25] Teaching Real-World Evidence: Protocol for a Systematic Review
    Lam, Ching
    van Velthoven, Michelle Helena
    Chaudhury, Hassan
    Meinert, Edward
    JMIR RESEARCH PROTOCOLS, 2020, 9 (01):
  • [26] Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
    Caronna, Edoardo
    Gallardo, Victor Jose
    Egeo, Gabriella
    Vazquez, Manuel Millan
    Castellanos, Candela Nieves
    Membrilla, Javier A.
    Vaghi, Gloria
    Rodriguez-Montolio, Joana
    Fabra, Neus Fabregat
    Sanchez-Caballero, Francisco
    Sanchez, Alex Jaimes
    Munoz-Vendrell, Albert
    Oliveira, Renato
    Garate, Gabriel
    Gonzalez-Osorio, Yesica
    Guisado-Alonso, Daniel
    Ornello, Raffaele
    Thunstedt, Cem
    Fernandez-Lazaro, Iris
    Torres-Ferrus, Marta
    Alpuente, Alicia
    Torelli, Paola
    Aurilia, Cinzia
    Pere, Raquel Lamas
    Castrillo, Maria Jose Ruiz
    De Icco, Roberto
    Sances, Grazia
    Broadhurst, Sarah
    Ong, Hui Ching
    Garcia, Andrea Gomez
    Campoy, Sergio
    Sanahuja, Jordi
    Cabral, Goncalo
    Blasco, Isabel Beltran
    Waliszewska-Prosol, Marta
    Pereira, Liliana
    Layos-Romero, Almudena
    Luzeiro, Isabel
    Dorado, Laura
    Escudero, Maria Rocio Alvarez
    May, Arne
    Lopez-Bravo, Alba
    Martins, Isabel Pavao
    Sundal, Christina
    Irimia, Pablo
    Ros, Alberto Lozano
    Gago-Veiga, Ana Beatriz
    Juanes, Fernando Velasco
    Ruscheweyh, Ruth
    Sacco, Simona
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (10) : 927 - 937
  • [27] Real-world effectiveness of fremanezumab in patients with migraine switching from another mAb targeting the CGRP pathway
    Waliszewska-Prosol, Marta
    Martelletti, Paolo
    DENTAL AND MEDICAL PROBLEMS, 2024, 61 (01) : 9 - 11
  • [28] Use of Structured Template and Reporting Tool for Real-World Evidence for Critical Appraisal of the Quality of Reporting of Real-World Evidence Studies: A Systematic Review
    Khambholja, Kapil
    Gehani, Manish
    VALUE IN HEALTH, 2023, 26 (03) : 427 - 434
  • [29] Real-world evidence data on the monoclonal antibody erenumab in migraine prevention: perspectives of treating physicians in Germany
    Andreas Straube
    Philipp Stude
    Charly Gaul
    Katrin Schuh
    Mirja Koch
    The Journal of Headache and Pain, 2021, 22
  • [30] Real-world evidence data on the monoclonal antibody erenumab in migraine prevention: perspectives of treating physicians in Germany
    Straube, Andreas
    Stude, Philipp
    Gaul, Charly
    Schuh, Katrin
    Koch, Mirja
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (01)
12345